Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)
Clinical trial NCT05804721 · COMPLETED
Trial details
- NCT number
- NCT05804721
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2022-11-07
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.